Skip to content

LivaNova LIVN Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
Globus Medical logo
Globus MedicalGMED
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's business combination, contingent consideration, liability?
LivaNova (LIVN) reported business combination, contingent consideration, liability of $102.73M in Q1 2026.
How has LivaNova's business combination, contingent consideration, liability changed year-over-year?
LivaNova's business combination, contingent consideration, liability increased by 20.7% year-over-year, from $85.14M to $102.73M.
What is the long-term trend for LivaNova's business combination, contingent consideration, liability?
Over 5 years (2020 to 2025), LivaNova's business combination, contingent consideration, liability has grown at a 0.5% compound annual growth rate (CAGR), from $89.85M to $92.08M.